Skip to main content
Print Save

Methscopolamine / pseudoephedrine Pregnancy and Breastfeeding Warnings

Methscopolamine / pseudoephedrine is also known as: AlleRx Dose Pack (AM Dose), Allerx-D, Amdry-D, Extendryl PSE, Respivent-D, Sudatrate

Methscopolamine / pseudoephedrine Pregnancy Warnings

Methscopolamine-pseudoephedrine has been assigned to pregnancy category C by the FDA. There are no controlled data in human pregnancy. Methscopolamine-pseudoephedrine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Methscopolamine / pseudoephedrine Breastfeeding Warnings

There are no data on the excretion of methscopolamine-pseudoephedrine into human milk. The manufacturer recommends that a decision be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. PSE 120/MSC 2.5 (methscopolamine-pseudoephedrine)." Cypress Pharmaceutical Inc, Madison, MS.

References for breastfeeding information

  1. "Product Information. PSE 120/MSC 2.5 (methscopolamine-pseudoephedrine)." Cypress Pharmaceutical Inc, Madison, MS.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer